サンプル依頼リスト カート
  • English
  • Korean
表紙：変形性関節症の世界市場レポート 2024年
市場調査レポート
商品コード
1415769

変形性関節症の世界市場レポート 2024年

Osteoarthritis Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
変形性関節症の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

変形性関節症の市場規模は近年急速に拡大しています。2023年の62億4,000万米ドルから2024年には68億7,000万米ドルに、CAGR10.1％で拡大します。実績期間の成長は、高齢化、肥満の流行、画像診断の進歩、疼痛管理に起因しています。

変形性関節症市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR9.0％で96億9,000万米ドルに成長します。予測期間の成長は、非薬理学的アプローチ、疾患修飾薬（dmoads）、個別化医療、遠隔医療、遠隔モニタリングに起因しています。予測期間における主な動向には、再生療法、ウェアラブルデバイス、診断における人工知能、デジタルヘルスツールなどが含まれます。

変形性関節症市場の成長は、肥満関連疾患の有病率の上昇に大きく影響されると予測されます。肥満関連疾患は、過剰な体脂肪によって生じる健康問題のスペクトルを包含します。この状態は通常、カロリー摂取量とカロリー消費量の不均衡から生じ、多くの場合、高度に加工された食品の消費と過度のアルコール摂取に関連しています。肥満は、関節への負担を増加させ、炎症を誘発し、関節への負担を増加させるホルモンの変化を引き起こすことにより、変形性関節症の発症に関与する可能性があります。例えば、世界肥満連合が発表した「World Obesity Atlas 2022」によると、2030年までに世界で10億人（男性では7人に1人、女性では5人に1人）が肥満と闘うことになると予測されています。さらに、この動向はエスカレートし続け、2035年には世界人口の51％に相当する40億人が過体重または肥満に分類されると推定されています。したがって、肥満関連疾患の急増が変形性関節症市場拡大の重要な促進要因となっています。

鎮痛剤の利用増加は、変形性関節症市場成長の重要な起爆剤となると思われます。鎮痛剤には、不快感を軽減して痛みを和らげるように設計された薬や物質が含まれます。様々な症状や怪我に伴う痛みを緩和する上で極めて重要な役割を果たしています。効果的な疼痛管理の必要性から、変形性関節症の疼痛管理における鎮痛剤の広範な応用は、変形性関節症市場に大きな影響を与える可能性を秘めています。この動向は需要の増加につながり、治療プロトコルに影響を及ぼし、研究開発イニシアチブを刺激し、この疾患に対する認識を高める可能性があります。その一例として、2022年6月にConsumer Healthcare Products Associationが発表したところによると、回答者の約80％が、過去2年間に市販の鎮痛剤を使用した割合が横ばい（49％）または増加（30％）したと回答しています。その結果、鎮痛剤の普及が変形性関節症市場の成長を促進しています。

2023年の変形性関節症市場では北米が最大地域でした。変形性関節症レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の変形性関節症市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 薬剤
  • 手術
  • 治療
  • 世界の変形性関節症市場、診断別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • イメージング
  • 関節流体解析
  • 世界の変形性関節症市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 非経口
  • 外用
  • 経口
  • 世界の変形性関節症市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 変形性膝関節症
  • 変形性脊椎関節症
  • 足と足首の変形性関節症
  • 変形性肩関節症
  • 手の変形性関節症
  • 世界の変形性関節症市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院
  • 医療機関

第7章 地域および国の分析

  • 世界の変形性関節症市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の変形性関節症市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 変形性関節症市場の競合情勢
  • 変形性関節症市場の企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson
    • Merck Sharp &Dohme Corp.
    • Abbvie Inc.
    • Bayer AG

第31章 その他の主要および革新的な企業

  • Novartis AG
  • Sanofi SA
  • AstraZeneca plc
  • Abbott Laboratories Incorporation
  • Eli Lilly and Company
  • Boehringer Ingelheim
  • Novo Nordisk A/S
  • Reckitt Benckiser Group plc
  • Teva Pharmaceutical Industries Ltd.
  • Regeneron Pharmaceuticals Inc.
  • Mylan N.V.
  • Astellas Pharma Inc.
  • Zimmer Biomet Holdings Inc.
  • Eisai Co. Ltd.
  • Horizon Therapeutics plc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12368

“Osteoarthritis Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on osteoarthritis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for osteoarthritis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The osteoarthritis market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Treatment: Medication; Surgery; Therapy
  • 2) By Diagnosis: Imaging; Joint Fluid Analysis
  • 3) By Route Of Administration: Parenteral Route; Topical Route; Oral Route
  • 4) By Disease Type: Knee Osteoarthritis; Spine Osteoarthritis; Foot And Ankle Osteoarthritis; Shoulder Osteoarthritis; Hand Osteoarthritis
  • 5) By End-User: Hospitals; Medical Institutes
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck Sharp & Dohme Corp.; Abbvie Inc.; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Osteoarthritis is a type of arthritis that specifically impacts the joints, commonly affecting areas like the hands, knees, hips, neck, and lower back. This condition develops as the protective cartilage covering the ends of bones gradually wears away. The goal of osteoarthritis treatment is to alleviate pain, enhance joint function, and slow down the progression of the disease.

The primary treatments for osteoarthritis involve medication, surgical interventions, and therapy. Medication involves the use of drugs or pharmaceuticals to treat or alleviate the condition. Osteoarthritis pain can be managed with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and opioids. Diagnosis typically includes imaging studies and joint fluid analysis. Medications can be administered via different routes, including parenteral, topical, and oral, and are employed for treating various types of osteoarthritis, such as knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, and hand osteoarthritis. These treatments are primarily administered by healthcare professionals in hospitals and medical institutes.

The osteoarthritis market research report is one of a series of new reports from The Business Research Company that provides osteoarthritis market statistics, including osteoarthritis industry global market size, regional shares, competitors with an osteoarthritis market share, detailed osteoarthritis market segments, market trends and opportunities and any further data you may need to thrive in the osteoarthritis industry. This osteoarthritis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The osteoarthritis market size has grown rapidly in recent years. It will grow from $6.24 billion in 2023 to $6.87 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to aging population, obesity epidemic, advances in imaging, pain management.

The osteoarthritis market size is expected to see strong growth in the next few years. It will grow to $9.69 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to non-pharmacological approaches, disease-modifying osteoarthritis drugs (dmoads), personalized medicine, telehealth and remote monitoring. Major trends in the forecast period include regenerative therapies, wearable devices, artificial intelligence in diagnosis, digital health tools.

The growth of the osteoarthritis market is anticipated to be significantly influenced by the rising prevalence of obesity-related disorders. Obesity-related disorders encompass a spectrum of health issues that can emerge due to excess body fat. This condition typically results from an imbalance between caloric intake and expenditure, often associated with the consumption of highly processed foods and excessive alcohol consumption. Obesity can contribute to the development of osteoarthritis by exerting increased stress on joints, inciting inflammation, and causing hormonal changes that elevate the burden on the joints. For example, according to the World Obesity Atlas 2022, published by the World Obesity Federation, it is projected that by 2030, 1 billion individuals worldwide, comprising 1 in 7 men and 1 in 5 women, will grapple with obesity. Furthermore, the report suggests that this trend will continue to escalate, with an estimated 4 billion people, equivalent to 51% of the global population, being classified as either overweight or obese by 2035. Thus, the surge in obesity-related disorders is a key driver behind the expansion of the osteoarthritis market.

The increasing utilization of pain relievers is poised to be a significant catalyst for the growth of the osteoarthritis market. Pain relievers encompass medications or substances designed to alleviate pain by diminishing the perception of discomfort. They play a pivotal role in mitigating pain associated with various conditions or injuries. The widespread application of pain relievers in the management of osteoarthritis, driven by the imperative need for effective pain management, holds considerable potential to impact the osteoarthritis market. This trend can lead to heightened demand, exert an influence on treatment protocols, stimulate research and development initiatives, and elevate awareness surrounding the condition. As an illustrative instance, in June 2022, the Consumer Healthcare Products Association reported that about 80% of respondents expressed that their utilization of over-the-counter pain relievers has either remained consistent (49%) or increased (30%) over the past two years. Consequently, the prevalent use of pain relievers is propelling the growth of the osteoarthritis market.

The osteoarthritis market's expansion during the forecast period faces a significant impediment in the form of high treatment costs. The elevated cost associated with osteoarthritis treatment can pose formidable barriers to access and treatment adherence, particularly affecting individuals with limited insurance coverage or those who lack insurance altogether. This circumstance often leads to delayed diagnosis and treatment, thereby exacerbating the progression of the disease and heightening the risk of complications. As an example, in 2021, the National Library of Medicine, a reputable biomedical library, reported an estimated annual cost range for osteoarthritis management per individual, spanning from $700 to $15,600. Consequently, the elevated cost of treatments represents a hindrance to the growth of the osteoarthritis market.

Major companies engaged in the osteoarthritis market are directing their efforts toward the development of novel products and advanced treatment modalities, including small molecule inhibitors, intra-articular hyaluronic acid injections, and single-injection viscosupplements, to fortify their foothold in the market. For instance, in August 2021, Seikagaku Corporation, a pharmaceutical and medical device company headquartered in Japan, introduced HyLink, a single-injection viscosupplement intended for intra-articular administration to address knee osteoarthritis. The core component of this product is a crosslinked hyaluronate hydrogel created using Seikagaku's proprietary crosslinking technique. HyLink is anticipated to offer enduring relief from symptoms with a minimal 3ml dosage, as the highly viscoelastic hyaluronate hydrogel remains within the knee joint cavity for an extended period, enhancing lubrication and reducing pain.

In July 2022, Bioventus Inc., a medical device company based in the United States, completed the acquisition of CartiHeal Ltd. for a sum of $450 million. This strategic acquisition is expected to enhance Bioventus' joint preservation technology. It bolsters Bioventus' standing as a leader in the joint preservation technology sector, aligning with Bioventus' objectives related to sports medicine and comprehensive joint reconstruction. CartiHeal Ltd., headquartered in Israel, specializes in the development of medical devices designed for the treatment of cartilage and osteochondral defects in both arthritic and non-arthritic knee joints. This acquisition is set to augment Bioventus' capabilities and offerings in this domain.

Major players in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

North America was the largest region in the osteoarthritis market in 2023. The regions covered in osteoarthritis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the osteoarthritis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The osteoarthritis market consists of revenues earned by entities by providing services such as physical therapy, occupational therapy, weight management, exercise and physical activity, patient education, self-management programs and joint protection techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. The osteoarthritis market also includes sales of viscosupplementation agents, analgesics, corticosteroids and assistive devices such as braces, canes, or shoe inserts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Osteoarthritis Market Characteristics

3. Osteoarthritis Market Trends And Strategies

4. Osteoarthritis Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Osteoarthritis Market Size and Growth

  • 5.1. Global Osteoarthritis Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Osteoarthritis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Osteoarthritis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Osteoarthritis Market Segmentation

  • 6.1. Global Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medication
  • Surgery
  • Therapy
  • 6.2. Global Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Imaging
  • Joint Fluid Analysis
  • 6.3. Global Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Parenteral Route
  • Topical Route
  • Oral Route
  • 6.4. Global Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Knee Osteoarthritis
  • Spine Osteoarthritis
  • Foot And Ankle Osteoarthritis
  • Shoulder Osteoarthritis
  • Hand Osteoarthritis
  • 6.5. Global Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Medical Institutes

7. Osteoarthritis Market Regional And Country Analysis

  • 7.1. Global Osteoarthritis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Osteoarthritis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Osteoarthritis Market

  • 8.1. Asia-Pacific Osteoarthritis Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Osteoarthritis Market

  • 9.1. China Osteoarthritis Market Overview
  • 9.2. China Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Osteoarthritis Market

  • 10.1. India Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Osteoarthritis Market

  • 11.1. Japan Osteoarthritis Market Overview
  • 11.2. Japan Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Osteoarthritis Market

  • 12.1. Australia Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Osteoarthritis Market

  • 13.1. Indonesia Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Osteoarthritis Market

  • 14.1. South Korea Osteoarthritis Market Overview
  • 14.2. South Korea Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Osteoarthritis Market

  • 15.1. Western Europe Osteoarthritis Market Overview
  • 15.2. Western Europe Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Osteoarthritis Market

  • 16.1. UK Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Osteoarthritis Market

  • 17.1. Germany Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Osteoarthritis Market

  • 18.1. France Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Osteoarthritis Market

  • 19.1. Italy Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Osteoarthritis Market

  • 20.1. Spain Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Osteoarthritis Market

  • 21.1. Eastern Europe Osteoarthritis Market Overview
  • 21.2. Eastern Europe Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Osteoarthritis Market

  • 22.1. Russia Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Osteoarthritis Market

  • 23.1. North America Osteoarthritis Market Overview
  • 23.2. North America Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Osteoarthritis Market

  • 24.1. USA Osteoarthritis Market Overview
  • 24.2. USA Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Osteoarthritis Market

  • 25.1. Canada Osteoarthritis Market Overview
  • 25.2. Canada Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Osteoarthritis Market

  • 26.1. South America Osteoarthritis Market Overview
  • 26.2. South America Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Osteoarthritis Market

  • 27.1. Brazil Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Osteoarthritis Market

  • 28.1. Middle East Osteoarthritis Market Overview
  • 28.2. Middle East Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Osteoarthritis Market

  • 29.1. Africa Osteoarthritis Market Overview
  • 29.2. Africa Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Osteoarthritis Market Competitive Landscape And Company Profiles

  • 30.1. Osteoarthritis Market Competitive Landscape
  • 30.2. Osteoarthritis Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck Sharp & Dohme Corp.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbvie Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bayer AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Osteoarthritis Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. Sanofi SA
  • 31.3. AstraZeneca plc
  • 31.4. Abbott Laboratories Incorporation
  • 31.5. Eli Lilly and Company
  • 31.6. Boehringer Ingelheim
  • 31.7. Novo Nordisk A/S
  • 31.8. Reckitt Benckiser Group plc
  • 31.9. Teva Pharmaceutical Industries Ltd.
  • 31.10. Regeneron Pharmaceuticals Inc.
  • 31.11. Mylan N.V.
  • 31.12. Astellas Pharma Inc.
  • 31.13. Zimmer Biomet Holdings Inc.
  • 31.14. Eisai Co. Ltd.
  • 31.15. Horizon Therapeutics plc

32. Global Osteoarthritis Market Competitive Benchmarking

33. Global Osteoarthritis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Osteoarthritis Market

35. Osteoarthritis Market Future Outlook and Potential Analysis

  • 35.1 Osteoarthritis Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Osteoarthritis Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Osteoarthritis Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer